Derivation of a triple mosaic adenovirus for cancer gene therapy

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Tang, Yizhe ^a   Wu, Hongju ^a   Ugai, Hideyo ^a   Matthews, Qiana L ^a,b   Curiel, David T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CAPSID PROTEIN; CAPSID PROTEIN 9; GANCICLOVIR; POLYLYSINE; RED FLUORESCENT PROTEIN; THYMIDINE KINASE; UNCLASSIFIED DRUG; HEXON CAPSID PROTEIN, ADENOVIRUS; PHOTOPROTEIN; RECOMBINANT DNA;

ARTICLE; CANCER CELL; CANCER GENE THERAPY; CARBOXY TERMINAL SEQUENCE; CELL KILLING; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; VIRAL GENE THERAPY; VIRUS PARTICLE; ADENOVIRUS; ADENOVIRUS INFECTION; CELL DEATH; CELL LINE; FLUORESCENCE MICROSCOPY; GENE THERAPY; GENE VECTOR; GENETIC ENGINEERING; GENETICS; METABOLISM; METHODOLOGY; NEOPLASM; SURFACE PROPERTY; ULTRASTRUCTURE; VIRION; VIRUS ATTACHMENT; VIRUS CAPSID; WESTERN BLOTTING;

ADENOVIRIDAE; HUMAN HERPESVIRUS 1; MIRIDAE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; BLOTTING, WESTERN; CAPSID; CAPSID PROTEINS; CELL DEATH; CELL LINE; DNA, RECOMBINANT; GENE THERAPY; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; NEOPLASMS; POLYLYSINE; SURFACE PROPERTIES; THYMIDINE KINASE; VIRION; VIRUS ATTACHMENT;

EID: 77949528771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008526     Document Type: Article

References (36)

1. Edelstein ML, Abedi MR, Wixon J, Edelstein RM (2004) Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med 6: 597-602.
2. Wadhwa PD, Zielske SP, Roth JC, Ballas CB, Bowman JE, et al. (2002) Cancer gene therapy: scientific basis. Annu Rev Med 53: 437-452.
3. Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 9: 833-842.
4. Le LP, Le HN, Dmitriev IP, Davydova JG, Gavrikova T, et al. (2006) Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling. J Natl Cancer Inst 98: 203-214.
5. Yang M, Baranov E, Jiang P, Sun FX, Li XM, et al. (2000) Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proc Natl Acad Sci U S A 97: 1206-1211.
6. Mathis JM, Williams BJ, Sibley DA, Carroll JL, Li J, et al. (2006) Cancer-specific targeting of an adenovirus-delivered herpes simplex virus thymidine kinase suicide gene using translational control. J Gene Med 8: 1105-1120.
7. Mocanu JD, Yip KW, Alajez NM, Shi W, Li JH, et al. (2007) Imaging the modulation of adenoviral kinetics and biodistribution for cancer gene therapy. Mol Ther 15: 921-929.
8. Glasgow JN, Everts M, Curiel DT (2006) Transductional targeting of adenovirus vectors for gene therapy. Cancer Gene Ther 13: 830-844.
9. Waehler R, Russell SJ, Curiel DT (2007) Engineering targeted viral vectors for gene therapy. Nat Rev Genet 8: 573-587.
10. Le LP, Everts M, Dmitriev IP, Davydova JG, Yamamoto M, et al. (2004) Fluorescently labeled adenovirus with pIX-EGFP for vector detection. Mol Imaging 3: 105-116.
11. Meulenbroek RA, Sargent KL, Lunde J, Jasmin BJ, Parks RJ (2004) Use of adenovirus protein IX (pIX) to display large polypeptides on the virion- generation of fluorescent virus through the incorporation of pIX-GFP. Mol Ther 9: 617-624.
12. Li J, Le L, Sibley DA, Mathis JM, Curiel DT (2005) Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion. Virology 338: 247-258.
13. Dmitriev IP, Kashentseva EA, Curiel DT (2002) Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J Virol 76: 6893-6899.
14. Matthews QL, Sibley DA, Wu H, Li J, Stoff-Khalili MA, et al. (2006) Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion. Mol Imaging 5: 510-519.
15. Tang Y, Le LP, Matthews QL, Han T, Wu H, et al. (2008) Derivation of a triple mosaic adenovirus based on modification of the minor capsid protein IX. Virology 377: 391-400.
16. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
17. Maizel JV Jr, White DO, Scharff MD (1968) The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36: 115-125.
18. Wu H, Han T, Belousova N, Krasnykh V, Kashentseva E, et al. (2005) Identification of sites in adenovirus hexon for foreign peptide incorporation. J Virol 79: 3382-3390.
19. Akalu A, Liebermann H, Bauer U, Granzow H, Seidel W (1999) The subgenus- specific C-terminal region of protein IX is located on the surface of the adenovirus capsid. J Virol 73: 6182-6187.
20. Vellinga J, Rabelink MJ, Cramer SJ, van den Wollenberg DJ, Van der Meulen H, et al. (2004) Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX. J Virol 78: 3470-3479.
21. Saban SD, Nepomuceno RR, Gritton LD, Nemerow GR, Stewart PL (2005) CryoEM structure at 9A resolution of an adenovirus vector targeted to hematopoietic cells. J Mol Biol 349: 526-537.
22. Campos SK, Barry MA (2004) Rapid construction of capsid-modified adenoviral vectors through bacteriophage lambda Red recombination. Hum Gene Ther 15: 1125-1130.
23. Shenk T (1996) Adenoviridae: The Viruses and Their Replication; Fields BN, Knipe DM, Howley PM, editors. Philadelphia: Lippincott - Raven. pp 2111-2148.
24. Le LP, Li J, Ternovoi VV, Siegal GP, Curiel DT (2005) Fluorescently tagged canine adenovirus via modification with protein IX-enhanced green fluorescent protein. J Gen Virol 86: 3201-3208.
25. Takayama K, Reynolds PN, Short JJ, Kawakami Y, Adachi Y, et al. (2003) A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism. Virology 309: 282-293.
26. Pereboeva L, Komarova S, Mahasreshti PJ, Curiel DT (2004) Fiber-mosaic adenovirus as a novel approach to design genetically modified adenoviral vectors. Virus Res 105: 35-46.
27. Tsuruta Y, Pereboeva L, Glasgow JN, Rein DT, Kawakami Y, et al. (2007) A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway. Clin Cancer Res 13: 2777-2783.
28. Ugai H, Wang M, Le LP, Matthews DA, Yamamoto M, et al. (2009) In Vitro Dynamic Visualization Analysis of Fluorescently Labeled Minor Capsid Protein IX and Core Protein V by Simultaneous Detection. J Mol Biol.
29. Donnelly ML, Gani D, Flint M, Monaghan S, Ryan MD (1997) The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol 78 (Pt1): 13-21.
30. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, et al. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82: 1013-1025.
31. Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, et al. (2004) Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat Biotechnol 22: 589-594.
32. Bobardt MD, Chatterji U, Selvarajah S, Van der Schueren B, David G, et al. (2007) Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cells. J Virol 81: 395-405.
33. Bomsel M (1997) Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med 3: 42-47.
34. Di Pasquale G, Chiorini JA (2006) AAV transcytosis through barrier epithelia and endothelium. Mol Ther 13: 506-516.
35. Tang Y, Han T, Everts M, Zhu ZB, Gillespie GY, et al. (2007) Directing adenovirus across the blood-brain barrier via melanotransferrin (P97) transcy- tosis pathway in an in vitro model. Gene Ther 14: 523-532.
36. Zhu ZB, Makhija SK, Lu B, Wang M, Rivera AA, et al. (2004) Transport across a polarized monolayer of Caco-2 cells by transferrin receptor-mediated adenovirus transcytosis. Virology 325: 116-128.